Fragile X Syndrome

J. Tiago Goncalves, C. Portera-Cailliau

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Fragile X syndrome (FXS) is the leading cause of inherited intellectual disability and the best understood single-gene cause of autism. It is most often caused by a trinucleotide repeat expansion in the FMR1 (fragile X mental retardation 1) gene on the X chromosome, first identified in 1991, resulting in the transcriptional repression of the gene. Intellectual disability, autistic traits, abnormal facial features, and macroorchidism are among the most common clinical features in affected individuals. Although the brains of individuals with FXS have few gross anatomical defects, at the cytological level there is an overabundance of immature dendritic spines of neurons in the cerebral cortex. Similar spine defects are reproduced in the Fmr1 knockout mouse model of FXS. In addition to spine dysgenesis, diminished inhibition and excessive metabotropic glutamate receptor signaling in the brain are the most widely studied alterations in the mutant mice. A major area of investigation is the identification of signaling pathways regulated by the fragile X mental retardation protein (FMRP). FMRP is an mRNA-binding protein that represses the translation of key synaptic proteins, presumably by stalling ribosomal translocation on its target RNAs. Through this work, a variety of molecules implicated in the structural and functional synaptic abnormalities in Fmr1 null mice have already been identified as potential therapeutic targets and are now being pursued in several FXS clinical trials.

Original languageEnglish (US)
Title of host publicationBrenner's Encyclopedia of Genetics
Subtitle of host publicationSecond Edition
PublisherElsevier Inc.
Pages106-109
Number of pages4
ISBN (Electronic)9780080961569
ISBN (Print)9780123749840
DOIs
StatePublished - Feb 27 2013
Externally publishedYes

Fingerprint

Fragile X Syndrome
Fragile X Mental Retardation Protein
Genes
Intellectual Disability
Brain
brain
Trinucleotide Repeats
Defects
Metabotropic Glutamate Receptors
Spine
genes
proteins
cerebral cortex
Trinucleotide Repeat Expansion
mice
X chromosome
Chromosomes
X-Linked Genes
Dendritic Spines
translation (genetics)

Keywords

  • Autism
  • Dendritic spine
  • Fragile X mental retardation protein
  • Fragile X syndrome
  • Long-term depression
  • Long-term potentiation
  • Mental impairment
  • Metabotropic glutamate receptor
  • Methylation
  • Plasticity
  • Synapse
  • Trinucleotide repeat

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Goncalves, J. T., & Portera-Cailliau, C. (2013). Fragile X Syndrome. In Brenner's Encyclopedia of Genetics: Second Edition (pp. 106-109). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-374984-0.00554-4

Fragile X Syndrome. / Goncalves, J. Tiago; Portera-Cailliau, C.

Brenner's Encyclopedia of Genetics: Second Edition. Elsevier Inc., 2013. p. 106-109.

Research output: Chapter in Book/Report/Conference proceedingChapter

Goncalves, JT & Portera-Cailliau, C 2013, Fragile X Syndrome. in Brenner's Encyclopedia of Genetics: Second Edition. Elsevier Inc., pp. 106-109. https://doi.org/10.1016/B978-0-12-374984-0.00554-4
Goncalves JT, Portera-Cailliau C. Fragile X Syndrome. In Brenner's Encyclopedia of Genetics: Second Edition. Elsevier Inc. 2013. p. 106-109 https://doi.org/10.1016/B978-0-12-374984-0.00554-4
Goncalves, J. Tiago ; Portera-Cailliau, C. / Fragile X Syndrome. Brenner's Encyclopedia of Genetics: Second Edition. Elsevier Inc., 2013. pp. 106-109
@inbook{bfcfac003c574be58392143e0f256f89,
title = "Fragile X Syndrome",
abstract = "Fragile X syndrome (FXS) is the leading cause of inherited intellectual disability and the best understood single-gene cause of autism. It is most often caused by a trinucleotide repeat expansion in the FMR1 (fragile X mental retardation 1) gene on the X chromosome, first identified in 1991, resulting in the transcriptional repression of the gene. Intellectual disability, autistic traits, abnormal facial features, and macroorchidism are among the most common clinical features in affected individuals. Although the brains of individuals with FXS have few gross anatomical defects, at the cytological level there is an overabundance of immature dendritic spines of neurons in the cerebral cortex. Similar spine defects are reproduced in the Fmr1 knockout mouse model of FXS. In addition to spine dysgenesis, diminished inhibition and excessive metabotropic glutamate receptor signaling in the brain are the most widely studied alterations in the mutant mice. A major area of investigation is the identification of signaling pathways regulated by the fragile X mental retardation protein (FMRP). FMRP is an mRNA-binding protein that represses the translation of key synaptic proteins, presumably by stalling ribosomal translocation on its target RNAs. Through this work, a variety of molecules implicated in the structural and functional synaptic abnormalities in Fmr1 null mice have already been identified as potential therapeutic targets and are now being pursued in several FXS clinical trials.",
keywords = "Autism, Dendritic spine, Fragile X mental retardation protein, Fragile X syndrome, Long-term depression, Long-term potentiation, Mental impairment, Metabotropic glutamate receptor, Methylation, Plasticity, Synapse, Trinucleotide repeat",
author = "Goncalves, {J. Tiago} and C. Portera-Cailliau",
year = "2013",
month = "2",
day = "27",
doi = "10.1016/B978-0-12-374984-0.00554-4",
language = "English (US)",
isbn = "9780123749840",
pages = "106--109",
booktitle = "Brenner's Encyclopedia of Genetics",
publisher = "Elsevier Inc.",
address = "United States",

}

TY - CHAP

T1 - Fragile X Syndrome

AU - Goncalves, J. Tiago

AU - Portera-Cailliau, C.

PY - 2013/2/27

Y1 - 2013/2/27

N2 - Fragile X syndrome (FXS) is the leading cause of inherited intellectual disability and the best understood single-gene cause of autism. It is most often caused by a trinucleotide repeat expansion in the FMR1 (fragile X mental retardation 1) gene on the X chromosome, first identified in 1991, resulting in the transcriptional repression of the gene. Intellectual disability, autistic traits, abnormal facial features, and macroorchidism are among the most common clinical features in affected individuals. Although the brains of individuals with FXS have few gross anatomical defects, at the cytological level there is an overabundance of immature dendritic spines of neurons in the cerebral cortex. Similar spine defects are reproduced in the Fmr1 knockout mouse model of FXS. In addition to spine dysgenesis, diminished inhibition and excessive metabotropic glutamate receptor signaling in the brain are the most widely studied alterations in the mutant mice. A major area of investigation is the identification of signaling pathways regulated by the fragile X mental retardation protein (FMRP). FMRP is an mRNA-binding protein that represses the translation of key synaptic proteins, presumably by stalling ribosomal translocation on its target RNAs. Through this work, a variety of molecules implicated in the structural and functional synaptic abnormalities in Fmr1 null mice have already been identified as potential therapeutic targets and are now being pursued in several FXS clinical trials.

AB - Fragile X syndrome (FXS) is the leading cause of inherited intellectual disability and the best understood single-gene cause of autism. It is most often caused by a trinucleotide repeat expansion in the FMR1 (fragile X mental retardation 1) gene on the X chromosome, first identified in 1991, resulting in the transcriptional repression of the gene. Intellectual disability, autistic traits, abnormal facial features, and macroorchidism are among the most common clinical features in affected individuals. Although the brains of individuals with FXS have few gross anatomical defects, at the cytological level there is an overabundance of immature dendritic spines of neurons in the cerebral cortex. Similar spine defects are reproduced in the Fmr1 knockout mouse model of FXS. In addition to spine dysgenesis, diminished inhibition and excessive metabotropic glutamate receptor signaling in the brain are the most widely studied alterations in the mutant mice. A major area of investigation is the identification of signaling pathways regulated by the fragile X mental retardation protein (FMRP). FMRP is an mRNA-binding protein that represses the translation of key synaptic proteins, presumably by stalling ribosomal translocation on its target RNAs. Through this work, a variety of molecules implicated in the structural and functional synaptic abnormalities in Fmr1 null mice have already been identified as potential therapeutic targets and are now being pursued in several FXS clinical trials.

KW - Autism

KW - Dendritic spine

KW - Fragile X mental retardation protein

KW - Fragile X syndrome

KW - Long-term depression

KW - Long-term potentiation

KW - Mental impairment

KW - Metabotropic glutamate receptor

KW - Methylation

KW - Plasticity

KW - Synapse

KW - Trinucleotide repeat

UR - http://www.scopus.com/inward/record.url?scp=85043246496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043246496&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-374984-0.00554-4

DO - 10.1016/B978-0-12-374984-0.00554-4

M3 - Chapter

SN - 9780123749840

SP - 106

EP - 109

BT - Brenner's Encyclopedia of Genetics

PB - Elsevier Inc.

ER -